The mutation A341V in the S6 transmembrane segment of KCNQ1, the ␣-subunit of the slowly activating delayed-rectifier K ؉ (I Ks ) channel, predisposes to a severe long-QT1 syndrome with sympathetictriggered ventricular tachyarrhythmias and sudden cardiac death.
brane segment) was reported in a large South African founder population. 11 This hot-spot LQT1 mutation, found globally, results in an unusually severe clinical phenotype compared with other LQT1 mutations, irrespective of their amino acid location (transmembrane versus N/C terminal) or dominantnegative characteristics. 12 Brisk variations in autonomic response increase the arrhythmic risk in A341V LQT1 patients. 13 Also, polymorphisms in ␣and ␤-adrenergic receptors (enhancing the autonomic response) are found more often in symptomatic than nonsymptomatic KCNQ1-A341V carriers. 13 In the present study, we investigated the molecular control of I Ks during ␤AR stimulation, hypothesizing that A341V provides a useful case to advance understanding of the I Ks macromolecular signaling complex, and to obtain novel insights into the determinants of phenotypic severity by A341V and other LQT1 mutations.
Methods
An extended overview of the Methods is provided in the Online Data Supplement accompanying this article. A summary of the main aspects is given here.
Electrophysiological Characterization of Wild-Type and Mutant I Ks in Chinese Hamster Ovary Cells
Chinese hamster ovary (CHO) cells were transiently transfected with human KCNQ1 (WT, mutant or 1:1 WT plus mutant), human KCNE1, human Yotiao, and GFP. GFP-fluorescent cells were used for whole-cell patch-clamp analysis at room temperature. Cells were studied with standard pipette solution (containing in mmol/L K-aspartate 110, ATP-K 2 5, MgCl 2 1, CaCl 2 1, EGTA 11, HEPES 10; pHϭ7.3 with KOH) or with cAMP and okadaic acid (OA) added to the pipette solution to mimic the effect of ␤AR stimulation. In some experiments, the phosphomimetic substitution KCNQ1-S27D was used in combination with wild-type (WT) or mutant KCNQ1 to study the effects of mimicked phosphorylation instead of cAMP/OA. The substitution S27A was used to study I Ks in conditions in which S27 phosphorylation was prevented.
Computational Analysis of Mutation Effects on APD
A computational model of the canine epicardial myocyte that includes a detailed localized model of ␤AR stimulation 14 was used to study the effects of the A341V mutation. Parameters of the nonphosphorylated and phosphorylated populations of I Ks channels in this model were fitted to the experimental data obtained in the electrophysiological studies in CHO cells in the absence or presence of cAMP/OA, after correction for temperature and effects of the expression system. The cell model was used to simulate the effects of the A341V mutation on APD in the absence or presence of ␤AR stimulation.
Coimmunoprecipitation of KCNQ1 and Yotiao
For coimmunoprecipitation studies, CHO cells were transfected with KCNQ1-WT or KCNQ1-A341VϩKCNE1ϩYotiao. CHO cells were lysed and the KCNQ1 complex was precipitated with an anti-KCNQ1 antibody and protein G sepharose beads. Western blot analysis of whole-cell lysates or immunocomplexes was performed with anti-KCNQ1 and anti-Yotiao antibodies and the relative intensity of Yotiao signal (to KCNQ1 signal) was compared for WT and A341V samples.
Analysis of KCNQ1 Phosphorylation
For Western-blot experiments, phosphorylation of KCNQ1 was induced by incubating the CHO cells (KCNQ1-WTϩKCNE1ϩ Yotiao, KCNQ1-A341VϩKCNE1ϩYotiao, or nontransfected CHO cells as negative controls) at 37°C with 300 mol/L CPT-cAMP plus 0.2 mol/L OA or with control solution for 10 minutes. Western blot analysis was performed and membranes were probed with anti-KCNQ1-phospho-S27 and anti-KCNQ1 antibodies. The KCNQ1monomer band of approximately 70 kDa was quantified in both S27-phospho and total KCNQ1 blots to calculate the fraction of phosphorylated KCNQ1.
Colocalization Experiments
CHO cells were grown on coverslips and transfected with KCNQ1myc, KCNQ1-A341V-GFP, KCNE1, and Yotiao cDNAs. Stainings were made with mouse monoclonal anti-c-Myc-conjugated and Texas red-conjugated goat anti-mouse antibodies. The antibodyinduced patching technique was used for immunostaining. Coverslips were mounted in 75% glycerol, 0.02 mol/L TRIS-HCl (pHϭ8.0), 0.8% NaN 3 , 2% 1,4-diazabicyclo[2.2.2]octane (DABCO; pHϭ8.0) and cells analyzed under a confocal microscope 24 hours after transfection.
Data Analysis
Voltage dependence of activation (evaluated from normalized tailcurrent amplitudes) was fitted with a Boltzmann equation: I/I max ϭ1/ (1ϩexp((VϪV 1/2 )/k) to determine the membrane potential for halfmaximal activation (V 1/2 ) and the slope factor (k). Time courses of activation and deactivation were fitted with single exponential functions. Data are expressed as meanϮSEM. Unpaired Student t test or 1-way ANOVA with Tukey post hoc test were used to assess differences between groups. PϽ0.05 was considered statistically significant.
Results

KCNQ1-A341V Results in a Dominant-Negative Suppression of cAMP-Dependent Upregulation of I Ks on Top of a Dominant-Negative Reduction in Basal Current
The KCNQ1-A341 residue is located in the middle of the S6-transmembrane domain, just before the PAG "hinge" motif 15 and is extremely well conserved among the families of voltage-gated K ϩ channels (Online Figure I) .
We found that, consistent with previous results, 11 the KCNQ1-A341V mutation resulted in a significant reduction of I Ks . The I Ks -tail amplitude after 5-second depolarizing pulses at ϩ60 mV was reduced by 96% and 46% in homozygous (A341V Hom ) and heterozygous (A341V Het ) conditions, respectively ( Figure 1A and 1B) . A significant rightward shift in channel activation was also observed ( Figure 1C and 1D ). In addition, there was a significant slowing of activation kinetics (time constants at ϩ60 mV were 1306Ϯ156 ms, 1947Ϯ265 ms, and 7303Ϯ1486 ms in WT, A341V Het , and A341V Hom , respectively) as well as faster deactivation (time constants at Ϫ80 mV: 501Ϯ61 ms, 205Ϯ14 ms, and 144Ϯ24 ms; PϽ0.05 versus WT for both A341V Het and A341V Hom ). Together, these altered kinetics contributed to the dominant-negative reduction in repolarizing current for depolarizations of physiological duration in A341V Het (74% reduction in peak I Ks after 300-ms depolarizing pulses, not shown). No differences were found in the number of cells showing membrane expression or the fluorescence intensity at the membrane between WT and A341V Hom (Online Figure II) , indicating that the observed reduction in I Ks is unlikely to be due to reduced expression. We also found no differences in the effect of WT and A341V Hom on KCHN2 current, which has been reported for other traffickingdeficient KCNQ1 mutations (Online Figure III) .
Non-standard Abbreviations and Acronyms
To study the effect of simulated ␤AR (as part of sympathetic) stimulation on WT and A341V I Ks channels, transfected CHO cells were stimulated with cAMP/OA in the pipette solution. 5 WT I Ks was significantly upregulated in the presence of cAMP/OA ( Figure 1A , left panel; 63% increase in tail-current amplitude). In contrast, both A341V Het and A341V Hom channels showed a negligible increase in current amplitude ( Figure 1A and 1B). The leftward shift in I-V relationship that occurred during cAMP-dependent stimulation for WT I Ks channels was also absent ( Figure 1C and 1D). This cAMP desensitivity, even in A341V Het , suggested that I Ks modulation is under dominant-negative control, whereby presence of one defect subunit may be sufficient to abolish I Ks upregulation.
Effect of Combined Dominant-Negative A341V Effects on Ventricular Repolarization
Patients carrying the A341V mutation can show pronounced QTc prolongation (see Figure 2A ; adapted from Shimizu 16 ), and QTc is longer among symptomatic than among asymptomatic carriers. 11 Moreover, QTc duration can prolong during exercise, despite an increase in heart rate (Figure 2A , right panel 16 ).
We examined the effect of A341V on ventricular repolarization using a computational model of ␤AR stimulation in the canine ventricular myocyte (Online Figure IV , V). 14 The A341V mutation caused a major reduction in I Ks amplitude during the action potential, even in heterozygous conditions ( Figure 2B , bottom panels). Under basal conditions, I Ks plays a minor role in ventricular repolarization, and, consistently, loss of I Ks by A341V resulted only in minimal APD prolongation ( Figure 2B , top left; ⌬APDϭ2.6 ms). In contrast, during ␤AR stimulation APD was significantly prolonged in A341V Het versus WT ( Figure 2B , top right; ⌬APDϭ23 ms) at all pacing cycle lengths (CL; Figure 2C ). Thus, these modeling studies confirmed that the biophysical alterations to I Ks by A341V in heterozygous conditions result in a pronounced cellular action potential phenotype, predominantly during ␤AR stimulation, in line with the ECG changes observed in A341V carriers.
Mechanisms Underlying the Suppressed cAMP Responsiveness of A341V I Ks
The A341V mutation could disrupt the ␤AR modulation of I Ks through various mechanisms, including (1) disruption of the conformational changes occurring after phosphorylation of KCNQ1-S27; (2) disruption of KCNQ1 interaction with Yotiao thereby reducing local PKA availability; or (3) disruption of phosphorylation of S27, even in the presence of Yotiao (eg, by a defective transfer of PKA from C-terminal Yotiao to N-terminal S27).
Mechanism 1 was tested using the phosphomimetic substitution KCNQ1-S27D. Kurokawa et al 17 have previously shown that the S27D substitution reproduces most of the effects of ␤AR stimulation on I Ks . Indeed, in WT conditions, S27D led to an upregulation of I Ks -tail amplitudes ( Figure 3A and 3B, left panels) and a significant leftward shift of the half-maximal activation potential, similar to that observed after the application of cAMP/OA ( Figure 3C ). In contrast to cAMP/ OA, the S27D substitution resulted in a significant upregulation of A341V in both heterozygous and homozygous conditions ( Figure 3A and 3B middle and right panels), as well as a significant leftward shift in half-maximal activation potential ( Figure 3C ). These data refuted hypothesized mechanism 2 to explain the disrupted cAMP responsiveness of A341V.
Yotiao serves a dual function: not only is it required for phosphorylation of S27 by PKA, it also actively participates in the conformational changes of the channel complex after phosphorylation of S27. 17 We investigated the interaction between KCNQ1 and Yotiao through coimmunoprecipitation experiments in CHO cells expressing KCNQ1-WTϩ KCNE1ϩYotiao. Whole-cell lysates or immunocomplexes precipated from lysates using an anti-KCNQ1 antibody were probed with anti-KCNQ1 and anti-Yotiao antibodies ( Figure 4A ). Yotiao could be detected in both WT and A341V immunocomplexes but not in negative controls (nontransfected CHO cells or cells transfected with KCNQ1-WTϩKCNE1 but without Yotiao). The intensity of the Yotiao signal from immunocomplexes was corrected by the intensity of the KCNQ1 signal and results were normalized to WT conditions. In the presence of A341V, KCNQ1/ Yotiao interaction was not statistically different from WT Figure 1 . B, Tail I-V relationship for the conditions in A. Note different y-scales (indicated with arrows). C, Membrane potential resulting in halfmaximal activation. cAMP responsiveness of WT I Ks is characterized by a significant leftward shift in half-maximal activation (*PϽ0.05) that is not present in A341V Het or A341V Hom . In contrast, the S27D substitution results in significant shifts for all conditions. (0.92Ϯ0.10 of WT; Figure 4B ). Moreover, whereas A341Vmutant I Ks was markedly increased by the S27D substitution when Yotiao was cotransfected, there was no such increase in the absence of the anchoring protein ( Figure 4C ). We found no difference between basal WT I Ks in the presence or absence of Yotiao (not shown), indicating that the observed increase in KCNQ1-A341V-S27D was not due to enhanced expression and suggesting that Yotiao can indeed modulate I Ks in the presence of A341V-S27D. This indicated that hypothesized mechanism 2 cannot explain the dominant-negative reduction in cAMPdependent I Ks upregulation by the A341V mutation.
To test hypothesis 3, cells transfected with KCNQ1-WTϩKCNE1ϩYotiao or KCNQ1-A341VϩKCNE1ϩYotiao were incubated with either 300 mol/L membrane-permeable cAMP and 0.2 mol/L OA for 10 minutes, or with external solution. Lysates were run on SDS-PAGE, transferred onto PVDF membranes, and probed with anti-phospho-S27 KCNQ1 and anti-KCNQ1 antibodies. Nontransfected CHO cells were used as negative controls. A significant increase in the fraction of phosphorylated KCNQ1 was observed in response to stimulation with cAMP/OA in KCNQ1-WT ( Figure 5A ). Although increased phosphorylation was also observed in A341V-expressing cells, the fraction of phosphorylated I Ks channels was significantly lower than that in WT cells (by 25%), both for A341V Hom and A341V Het (Figure 5A and 5B) . Thus, defective phosphorylation of KCNQ1-A341V is responsible, at least partly, for the loss of cAMP-dependent I Ks upregulation.
Dominant-Negative Suppression of cAMP/PKA-Dependent I Ks Upregulation in LQT1
The reduction in KCNQ1-A341V phosphorylation is similar to that observed by Chen et al 18 for the Yotiao mutation S1570L. They also show a complete loss of I Ks enhancement (in this case due to reduced KCNQ1-Yotiao interaction). Combined, our data and those by Chen et al 18 suggest that cAMP-dependent I Ks upregulation is under strong dominant-negative control of KCNQ1-S27 phosphorylation, which is further supported by the functional finding of a striking loss of cAMP-dependent upregulation of heterozygous KCNQ1-A341V.
To further investigate the disruption of upregulation in heterozygous conditions, we first confirmed that KCNQ1-WT and KCNQ1-A341V are both expressed in the membrane by immunolocalization. Coexpression of KCNQ1-WT-c-Myc and KCNQ1-A341V-GFP constructs allowed simultaneous detection of WT (using an anti-c-Myc antibody) and A341V subunits. Figure 6 We next compared the loss of cAMP-dependent upregulation by KCNQ1-A341V with the LQT1 mutations KCNQ1-A344V, 19 KCNQ1-G589D, 20 and KCNQ1-K557E. Suppression of I Ks upregulation has previously been reported for the KCNQ1-G589D (KCNQ1-Fin) mutation, which disrupts the binding of Yotiao to the KCNQ1 C-terminus. 5 We have recently reported on the LQT1 mutation K557E found in a Dutch family with a relatively mild clinical phenotype in which cAMP-dependent I Ks enhancement is intact. 21 Responsiveness to cAMP was quantified by an increased tail-current amplitude over the entire population of cells studied ( Figure  7A ) as well as an increase in current amplitude for each individual cell during a 5-minute cAMP/OA wash-in protocol ( Figure 7B and 7C) . WT, heterozygous and homozygous K557E, and heterozygous and homozygous A344V all showed a pronounced responsiveness to cAMP. In contrast, A341V and G589D I Ks were unresponsive to stimulation, even when coexpressed with WT I Ks (Figure 7) . These results demonstrate that the loss of upregulation observed by A341V does not apply to the very similar mutation A344V (same amino acid substitution, only 3 residues apart and, based on the KCNQ1 homology model, in close proximity to A341; Online Figure I) . Nonetheless, dominant-negative suppression of cAMP-dependent I Ks upregulation is not exclusive for A341V, as indicated by our heterozygous G589D data.
To determine if the dominant-negative suppression of cAMP-dependent upregulation by A341V and G589D could be due to their common effects on KCNQ1-S27, and to investigate if alterations in KCNQ1-S27 alone can exert dominant-negative control of cAMP/PKA-dependent I Ks upregulation, independent of other known pathogenic mutations, we analyzed a 1:1 coexpression of WT KCNQ1 with KCNQ1-S27A (together with KCNE1 and Yotiao). This heterozygous S27A condition will disable the PKA phosphor-ylation site in approximately half of the KCNQ1 subunits. In contrast to the pronounced increase observed with cAMP/OA treatment in WT I Ks , there was no significant increase in I Ks -tail amplitude in heterozygous KCNQ1-S27A cells stimulated with cAMP/OA (Figure 8 ). Although there was still a small (but nonsignificant) increase in I Ks in heterozygous S27A, this increase was also present in cells with homozygous S27A expression after treatment with cAMP/OA (19% increase in tail current after 5-second depolarizing pulses to ϩ90 mV in both cases, not shown), and no significant differences were found between heterozygous S27A in the absence or presence of cAMP (Figure 8 ).
Discussion
In the present study, we provide novel mechanistic insights into cAMP-dependent upregulation of I Ks and its alteration by the S6 transmembrane LQT1 mutation A341V. We show that A341V confers a dominant-negative suppression of current upregulation. This loss of cAMP sensitivity is not due to a restriction of the conformational changes that occur after S27 phosphorylation but instead is due to the inability of PKA to phosphorylate KCNQ1-S27 despite the presence of Yotiao. The combined dominant-negative reduction in basal current and loss of cAMP sensitivity result in a pronounced prolongation of repolarization during ␤AR stimulation in a computational model. Moreover, we show that dominant-negative suppression of upregulation is shared by other LQT1 mutations that show loss of ␤AR modulation in homozygous conditions (eg, KCNQ1-G589D 5 ) and by heterozygous substitutions at S27. Our results suggest that tetrameric phosphorylation of KCNQ1 is required. This finding has important implications for the clinical severity of KCNQ1 mutations similar to A341V, because genetically heterozygous carriers will exhibit a "homozygous phenotype" with respect to ␤AR modulation. The present data stress the importance of investigating molecular signaling besides basal function of I Ks in the human congenital LQT syndrome.
Requirement of a Macromolecular Signaling Complex for I Ks Modulation
Specific macromolecular signaling is required for the modulation of voltage-gated ion channels. 22 Modulation of I Ks by (vertical dashed lines in B) . K557E and A344V are significantly upregulated by cAMP/OA. In contrast, A341V and G589D, which disrupt ␤AR sensitivity in homozygous conditions, have dominant-negative loss of cAMPdependent upregulation. In the absence of cAMP/OA, I Ks was stable and no significant difference in current amplitude between 5 minutes and 1 minute was found (leftmost bar). Figure 1) . Right, Averaged current traces at ϩ60 mV for WT I Ks or heterozygous expression of KCNQ1-S27A (nϭ9 and nϭ11) in the absence or presence of cAMP/OA, after cotransfection of KCNE1 and Yotiao. Heterozygous KCNQ1-S27A results in a dominant-negative reduction of cAMP-dependent I Ks upregulation that is indistinguishable from homozygous KCNQ1-S27A (not shown).
PKA requires a complex comprising KCNE1, 7 Yotiao, 5 and ␤-tubulin, 23 besides the pore-forming ␣-subunit KCNQ1. In pathological conditions, the composition of the macromolecular complex is even further complicated by the fact that most LQT1 mutations (including A341V) are inherited in an autosomal-dominant mode. In these conditions, variable mixtures of normal and mutant KCNQ1 subunits interact in the membrane-expressed I Ks channels.
KCNE1 and ␤-tubulin appear to operate downstream of channel phosphorylation in mediating the conformational changes that increase I Ks , because no difference in KCNQ1 phosphorylation was found after disruption of KCNE1 24 or microtubular interaction, 23 despite altered I Ks regulation. Interactions between KCNQ1 and KCNE1 have been reported for the extracellular, transmembrane, and intracellular parts of the subunits. 25, 26 Panaghie et al 25 have shown that KCNE1 interacts with the KCNQ1 pore region through residues F339 and F340. On the basis of a homology model of the structure of KCNQ1, Smith et al 27 determined that A341V does not face the lipid bilayer but instead interacts with S6-residues of other subunits (Online Figure I) . This makes it unlikely that A341 interacts directly with KCNE1. However, the A341V mutation may induce conformational changes in the KCNQ1-S6 segment that indirectly alter KCNQ1/KCNE1 interactions. Our S27D data show a clear upregulation in the presence of A341V, indicating that the interaction between KCNQ1 and KCNE1 is preserved, at least partly. In agreement, a recent study showed that KCNQ1-A341V in the absence of KCNE1 or in the presence of the mutant KCNE1-T58A results in nonfunctional channels. 28 However, the exact role of KCNE1 in influencing A341V-mutated I Ks and its upregulation requires further study.
Our S27D data also indicate that the Yotiao contribution downstream of phosphorylation is intact. Previously, Kurokawa et al 17 showed that S27D is unable to upregulate WT I Ks when Yotiao is not included. We confirm these results for A341V-mutant I Ks .
Analysis of KCNQ1 with a phospho-sensitive antibody indicated that despite the presence of Yotiao, phosphorylation of KCNQ1 is reduced in the presence of A341V. The exact molecular mechanism by which this occurs is currently unclear but may involve a reduced functional interaction between the KCNQ1 C-terminal-coupled Yotiao and the N-terminal phosphorylation site S27. Interestingly, however, the A341V mutation is located in the S6 transmembrane spanning domain of KCNQ1, a region that has not previously been reported to play a role in cAMP-dependent modulation of I Ks . However, the intact upregulation in the presence of the very similar mutation A344V suggests that the role of S6 in cAMP-dependent I Ks upregulation involves specific residues. The fact that A341 is an extremely conserved residue located just prior to the S6 "hinge domain" 15 (Online Figure I) indicates that even small perturbations of the amino-acid sequence at this position may cause pronounced alterations of channel structure.
Marx et al 5 have shown that the KCNQ1-G589D mutation in homozygous conditions results in loss of cAMP-dependent I Ks upregulation due to disruption of the KCNQ1-Yotiao interaction. We report that this abolishment of upregulation occurs also in heterozygous conditions. This illustrates that at least two KCNQ1 mutations (G589D and A341V), in different parts of the channel, show such dominant-negative suppression.
Marx et al 5 studies are clearly required to explore this. We found that the phosphomimetic substitutions KCNQ1-S468D/T470D were unable to upregulate I Ks (not shown), further indicating that S27 is the main phosphorylation site involved in cAMP-dependent I Ks upregulation. Importantly, we show here that the lack of cAMP-dependent I Ks upregulation was also observed on heterozygous KCNQ1-S27A substitution (a condition in which half of the N-terminal phosphorylation sites are disabled). In heterozygous conditions, a binomial distribution of subunit composition is expected in which 93.75% of the channels will have at least 1 mutation in the KCNQ1 tetramer. The complete lack of upregulation in this case indicates that PKA-dependent channel upregulation is under dominantnegative control by alterations at S27 in which a single defective subunit is sufficient to abolish upregulation and suggests a requirement for tetrameric phosphorylation or a strong cooperation between the four subunits in cAMPdependent channel modulation.
Mechanisms Underlying Phenotypic Severity of A341V and Role of Genetic Risk Modifiers
Schwartz et al 13 found that increased autonomic sensitivity, for example, resulting from polymorphisms in adrenergic receptors, was an arrhythmia-risk modifier in A341V mutations. This observation is in line with our computational simulations that indicate the most pronounced APD prolongation during high levels of ␤AR stimulation. The data presented in the present report readily explain why genetic variants of adrenergic receptors that boost sympathetic responsiveness of the heart are risk modifiers in A341V carriers due to the combined loss of basal I Ks and its cAMP-dependent upregulation.
Both A341V and G589D show complete loss of cAMPdependent upregulation in heterozygous conditions but have different clinical severities. Although there are important differences in peak basal currents at physiological potentials for 300-ms depolarizations (1.03Ϯ0.27 pA/pF versus 3.07Ϯ0.30 pA/pF at 20 mV for A341V Het and G589D Het , respectively; PϽ0.05), which may contribute to their phenotypic differences, it is clear that ionic mechanisms within I Ks itself do not provide the complete picture of repolarization instability in vivo. Variants in NOS1AP have been shown to affect QT duration in the normal population 30 and have been reported as risk modifiers in A341V carriers. Chang et al 31 have shown that NOS1AP overexpression affects repolarization through I Kr and I CaL . Previously, we have shown that the effect of reduced I Ks is larger when repolarization is impaired by pharmacological blockade of I Kr . 1 Thus, NOS1AP variants probably function next to KCNQ1 mutations, affecting among other things I Kr . The important role of I Ks as a repolarization reserve 1,32 may then partly explain their role as risk modifiers in A341V carriers. 33 
Conclusions
Loss of cAMP-dependent upregulation of I Ks , even under heterozygous conditions, on top of a dominant-negative reduction in basal current, is a biophysical characteristic of KCNQ1-A341V that may contribute to its phenotypic severity in patients. This loss of upregulation is related to reduced phosphorylation of KCNQ1 at S27. Moreover, we show in general that cAMP/PKA-dependent I Ks upregulation is under strong dominant-negative control of KCNQ1 phosphorylation at S27. These data have important implications for future studies of LQT1 mutations because they highlight the importance of studying the effects of heterozygous expression of mutations, similar to their occurrence in most patients, and they indicate that baseline I-V characteristics alone are insufficient to determine the electrophysiological consequences of LQT1 mutations. Finally, our data point to an as-yet unknown involvement of the S6 region of KCNQ1 at and/or around A341 in mediating ␤AR modulation of I Ks .
